Jennifer Sugarman

Jennifer Sugarman is a seasoned professional in clinical trial management with extensive experience in the biopharmaceutical industry. Currently serving as the Associate Director of Clinical Trial Management at Kriya Therapeutics, Inc., since March 2025, Jennifer previously held positions including Sr. Clinical Trial Manager at EyePoint Pharmaceuticals from May 2022 to December 2024, and Sr. Clinical Study Lead at Galapagos from July 2018 to June 2021. Additional roles include Clinical Trial Manager at AGTC and Associate Director of Clinical Affairs at pSivida/Eyepoint Pharmaceuticals. Jennifer's expertise encompasses managing global Phase 3 studies in Uveitis, providing oversight to CROs and clinical vendors. Educational qualifications include a Master of Public Health from Boston University and a Bachelor of Arts in Psychology from Keene State College.